Marea K. Harmon
FDA investigator
Appears on 1 document from 2005, mostly at sites in New Jersey. Most often cites production record review (21 CFR 211.192).
- 1
- Documents on file
- 12.0
- Observations per 483
- 2005
- First seen
- 2005
- Most recent
What they cite most
From 12 observations- 21 CFR 211.192Production record review3
- 21 CFR 314.81Other postmarketing reports2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.160General requirements1
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.194Laboratory records1
Activity by year
2005: 1
Where
New Jersey 1
Often inspects with
Is Marea K. Harmon coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2005-07-01 | 483 Able Laboratories, IncJul 1, 2005 · Cranbury, New Jersey | Cranbury, New Jersey | 12 |
About this profile
What does Marea K. Harmon inspect?
Marea K. Harmon appears on 1 document on file covering 1 site, mostly in New Jersey.
What do they cite most often?
21 CFR 211.192 (production record review), followed by 21 CFR 314.81 and 21 CFR 211.110.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Marea K. Harmon is dated Jul 1, 2005.